Theradiag : Results and Activity for the First Half of 2014 : Sales Trend Confirmed and in Line
Regulatory News : THERADIAG (Paris:ALTER) (ISIN: FR0004197747, Ticker: ALTER, PEA-PME eligible), a company specializing in theranostics and in vitro diagnostic (IVD), today reports its consolidated half-year results at the end of …